Moderna, Inc. — Director's Dealing 2024

May 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2024-05-06

Reporting Person: Horning Sandra (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-06	Stock Option (Right to Buy)	$122.13	A	5668	Acquired	2034-05-06	Common Stock (5668)	Direct
2024-05-06	Restricted Stock Units	$	A	979	Acquired		Common Stock (979)	Direct

Footnotes

F1: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

F2: Restricted stock units convert into common stock on a one-for-one basis.

F3: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.